This suggests that the efficacy of anti-tumor strategies involving the use of BrBzGSHCp2 can be ascribed to differences in cell lines and animal models used and, in general, is more efficient in a neoplastic context where Glo1 is expressed at high levels (4). Here, GLO1 is linked to neoplasm.